SHANG.FOS.PHARM.GR.H YC 1 Asset Resilience Ratio

Latest as of March 2026: 1.81%

SHANG.FOS.PHARM.GR.H YC 1 asset resilience ratio. SHANG.FOS.PHARM.GR.H YC 1 (08HH) has an Asset Resilience Ratio of 1.81% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 08HH total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

€2.23 Billion

≈ $2.60 Billion USD Cash + Short-term Investments

Total Assets

€122.97 Billion

≈ $143.76 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of SHANG.FOS.PHARM.GR.H YC 1 (2021–2025)

Asset resilience ratio of SHANG.FOS.PHARM.GR.H YC 1 from 2021 to 2025. This chart shows how SHANG.FOS.PHARM.GR.H YC 1's Asset Resilience Ratio has changed over time. See SHANG.FOS.PHARM.GR.H YC 1 free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down SHANG.FOS.PHARM.GR.H YC 1's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of SHANG.FOS.PHARM.GR.H YC 1.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€2.23 Billion	1.81%
Total Liquid Assets	€2.23 Billion	1.81%

Asset Resilience Insights

Limited Liquidity: SHANG.FOS.PHARM.GR.H YC 1 maintains only 1.81% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

SHANG.FOS.PHARM.GR.H YC 1 Industry Peers by Asset Resilience Ratio

Compare SHANG.FOS.PHARM.GR.H YC 1's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%
Zhejiang Medicine Co Ltd SHG:600216	Drug Manufacturers - Specialty & Generic	1.85%
Hunan Warrant Pharmaceutical Co. Ltd. A SHG:688799	Drug Manufacturers - Specialty & Generic	0.40%
Dezhan HealthCare Co Ltd SHE:000813	Drug Manufacturers - Specialty & Generic	0.09%
Chongqing Pharscin Pharmaceutical Co Ltd SHE:002907	Drug Manufacturers - Specialty & Generic	14.54%

SHANG.FOS.PHARM.GR.H YC 1 Asset Resilience Ratio by Year (2021–2025)

SHANG.FOS.PHARM.GR.H YC 1 asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for SHANG.FOS.PHARM.GR.H YC 1.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.88%	€2.25 Billion ≈ $2.64 Billion	€120.05 Billion ≈ $140.36 Billion	-0.33pp
2024-12-31	2.21%	€2.60 Billion ≈ $3.03 Billion	€117.46 Billion ≈ $137.32 Billion	+0.55pp
2023-12-31	1.66%	€1.89 Billion ≈ $2.21 Billion	€113.47 Billion ≈ $132.66 Billion	+0.80pp
2022-12-31	0.87%	€928.53 Million ≈ $1.09 Billion	€107.16 Billion ≈ $125.29 Billion	-3.68pp
2021-12-31	4.55%	€4.24 Billion ≈ $4.96 Billion	€93.31 Billion ≈ $109.08 Billion	--

pp = percentage points

About SHANG.FOS.PHARM.GR.H YC 1

F:08HH Germany Drug Manufacturers - Specialty & Generic

Market Cap

$1.18 Billion

€1.01 Billion EUR

Market Cap Rank

#7966 Global

#1082 in Germany

Share Price

€1.83

Change (1 day)

-3.02%

52-Week Range

€1.66 - €2.60

All Time High

€4.65